UK Lucentis Biosimilar Nod Offers Teva Potential First-Mover Advantage

Formycon-Bioeq Partnered Ongavia Receives First European Approval In UK

 
• By Dave Wallace
  
UK red on map of Europe
The UK has given Teva and partner Formycon a first European ranibizumab approval • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics